{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T08:55:59Z","timestamp":1792313759073,"version":"4.4.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>\n                    Extracorporeal therapies have been used to remove toxins from the body for over 50 years and have a greater role than ever before in the treatment of poisonings. Improvements in technology have resulted in increased efficacy of removing drugs and other toxins with hemodialysis, and newer extracorporeal therapy modalities have expanded the role of extracorporeal supportive care of poisoned patients. However, despite these changes, for at least the past three decades the most frequently dialyzed poisons remain salicylates, toxic alcohols, and lithium; in addition, the extracorporeal treatment of choice for therapeutic removal of nearly all poisonings remains intermittent hemodialysis. For the clinician, consideration of extracorporeal therapy in the treatment of a poisoning depends upon the characteristics of toxins amenable to extracorporeal removal (\n                    <jats:italic toggle=\"yes\">e.g.<\/jats:italic>\n                    , molecular mass, volume of distribution, protein binding), choice of extracorporeal treatment modality for a given poisoning, and when the benefit of the procedure justifies additive risk. Given the relative rarity of poisonings treated with extracorporeal therapies, the level of evidence for extracorporeal treatment of poisoning is not robust; however, extracorporeal treatment of a number of individual toxins have been systematically reviewed within the current decade by the Extracorporeal Treatment in Poisoning workgroup, which has published treatment recommendations with an improved evidence base. Some of these recommendations are discussed, as well as management of a small number of relevant poisonings where extracorporeal therapy use may be considered.\n                  <\/jats:p>","DOI":"10.2215\/cjn.02560319","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T15:05:55Z","timestamp":1566486355000},"page":"1408-1415","source":"Crossref","is-referenced-by-count":62,"title":["Extracorporeal Removal of Poisons and Toxins"],"prefix":"10.2215","volume":"14","author":[{"given":"Joshua David","family":"King","sequence":"first","affiliation":[{"name":"Division of Nephrology, University of Maryland, Baltimore, Maryland;"},{"name":"Maryland Poison Center, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz H.","family":"Kern","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany;"},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg\/Mannheim, Mannheim, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1210-7115","authenticated-orcid":false,"given":"Bernard G.","family":"Jaar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland;"},{"name":"Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland;"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; and"},{"name":"Nephrology Center of Maryland, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"B1-20230813","first-page":"275","article-title":"On the removal of diffusible substances from the circulating blood of living animals by dialysis","volume":"53","author":"Abel","year":"1914","journal-title":"J Pharmacol Exp Ther"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/sdi.12448","article-title":"Practice trends in the use of extracorporeal treatments for poisoning in four countries","volume":"29","author":"Ghannoum","year":"2016","journal-title":"Semin Dial"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/sdi.12238","article-title":"Available extracorporeal treatments for poisoning: Overview and limitations","volume":"27","author":"Ouellet","year":"2014","journal-title":"Semin Dial"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.ackd.2011.01.009","article-title":"Have advances in extracorporeal removal techniques changed the indications for their use in poisonings?","volume":"18","author":"Garlich","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"B5-20230813","first-page":"201","article-title":"Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodialysis","volume":"19","author":"Keller","year":"1983","journal-title":"Clin Nephrol"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2165\/00003088-200746110-00001","article-title":"Pharmacokinetic considerations in clinical toxicology: Clinical applications","volume":"46","author":"Roberts","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2165\/00003088-199732010-00002","article-title":"Principles of drug administration in renal insufficiency","volume":"32","author":"Lam","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"e0147159","DOI":"10.1371\/journal.pone.0147159","article-title":"Protein-bound uremic toxin profiling as a tool to optimize hemodialysis","volume":"11","author":"Eloot","year":"2016","journal-title":"PLoS One"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/15563650903167772","article-title":"Extracorporeal elimination in acute valproic acid poisoning","volume":"47","author":"Thanacoody","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3109\/15563650.2015.1035441","article-title":"Extracorporeal treatment for valproic acid poisoning: Systematic review and recommendations from the EXTRIP workgroup","volume":"53","author":"Ghannoum","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/15563650.2014.973572","article-title":"Extracorporeal treatment for carbamazepine poisoning: Systematic review and recommendations from the EXTRIP workgroup","volume":"52","author":"Ghannoum","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.annemergmed.2015.03.031","article-title":"Extracorporeal treatment for salicylate poisoning: Systematic review and recommendations from the EXTRIP workgroup","volume":"66","author":"Juurlink","year":"2015","journal-title":"Ann Emerg Med"},{"key":"B13-20230813","first-page":"165","article-title":"Performance of hemodialysis with novel medium cut-off dialyzers","volume":"32","author":"Kirsch","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.ackd.2011.02.006","article-title":"High cut-off dialysis membranes: Current uses and future potential","volume":"18","author":"Gondouin","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1592\/phco.27.11.1529","article-title":"Drug removal by plasmapheresis: An evidence-based review","volume":"27","author":"Ibrahim","year":"2007","journal-title":"Pharmacotherapy"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2215\/CJN.10021014","article-title":"Extracorporeal treatment for lithium poisoning: Systematic review and recommendations from the EXTRIP workgroup","volume":"10","author":"Decker","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1097\/CCM.0000000000001002","article-title":"Extracorporeal treatment for metformin poisoning: Systematic review and recommendations from the extracorporeal treatments in poisoning workgroup","volume":"43","author":"Calello","year":"2015","journal-title":"Crit Care Med"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/sdi.12247","article-title":"Principles and operational parameters to optimize poison removal with extracorporeal treatments","volume":"27","author":"Bouchard","year":"2014","journal-title":"Semin Dial"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/ki.1997.274","article-title":"Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study","volume":"51","author":"Leypoldt","year":"1997","journal-title":"Kidney Int"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1046\/j.1523-1755.2001.00003.x","article-title":"A simple method to estimate the required dialysis time for cases of alcohol poisoning","volume":"60","author":"Hirsch","year":"2001","journal-title":"Kidney Int"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"c1","DOI":"10.1159\/000286343","article-title":"Continuous renal replacement therapy does not have a clear role in the treatment of poisoning","volume":"115","author":"Kim","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1080\/15563650.2017.1388087","article-title":"2016 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 34th annual report","volume":"55","author":"Gummin","year":"2017","journal-title":"Clin Toxicol (Phila)"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/sdi.12246","article-title":"Hemoperfusion for the treatment of poisoning: Technology, determinants of poison clearance, and application in clinical practice","volume":"27","author":"Ghannoum","year":"2014","journal-title":"Semin Dial"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000318585","article-title":"Clinical outcome of hemoperfusion in poisoned patients","volume":"30","author":"Gil","year":"2010","journal-title":"Blood Purif"},{"key":"B25-20230813","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: The seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/15563650701502675","article-title":"Severe acute arsine poisoning treated by plasma exchange","volume":"45","author":"Song","year":"2007","journal-title":"Clin Toxicol (Phila)"},{"issue":"Suppl 3","key":"B27-20230813","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1478-3231.2011.02588.x","article-title":"Clearing of toxic substances: Are there differences between the available liver support devices?","volume":"31","author":"Krisper","year":"2011","journal-title":"Liver Int"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.kint.2018.03.026","article-title":"Use of extracorporeal treatments in the management of poisonings","volume":"94","author":"Ghannoum","year":"2018","journal-title":"Kidney Int"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/15563650.2012.683436","article-title":"The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: Guideline methodology","volume":"50","author":"Lavergne","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2796.2005.01521.x","article-title":"Methanol outbreak in Norway 2002-2004: Epidemiology, clinical features and prognostic signs","volume":"258","author":"Hovda","year":"2005","journal-title":"J Intern Med"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/CCM.0000000000000708","article-title":"Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: A systematic review and consensus statement","volume":"43","author":"Roberts","year":"2015","journal-title":"Crit Care Med"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ki.2014.60","article-title":"Intermittent hemodialysis is superior to continuous veno-venous hemodialysis\/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning","volume":"86","author":"Zakharov","year":"2014","journal-title":"Kidney Int"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1081\/CLT-100102445","article-title":"American academy of clinical toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad hoc committee","volume":"37","author":"Barceloux","year":"1999","journal-title":"J Toxicol Clin Toxicol"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/15563659809162613","article-title":"Glycolate kinetics and hemodialysis clearance in ethylene glycol poisoning. META study group","volume":"36","author":"Moreau","year":"1998","journal-title":"J Toxicol Clin Toxicol"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.paf.0000203221.17854.38","article-title":"Homicidal ethylene glycol intoxication: A report of a case","volume":"27","author":"Armstrong","year":"2006","journal-title":"Am J Forensic Med Pathol"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1503\/cmaj.061288","article-title":"Falsely elevated point-of-care lactate measurement after ingestion of ethylene glycol","volume":"176","author":"Brindley","year":"2007","journal-title":"CMAJ"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s13181-010-0061-2","article-title":"Massive ethylene glycol ingestion treated with fomepizole alone-a viable therapeutic option","volume":"6","author":"Buchanan","year":"2010","journal-title":"J Med Toxicol"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2215\/CJN.03220807","article-title":"Toxic alcohol ingestions: Clinical features, diagnosis, and management","volume":"3","author":"Kraut","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B39-20230813","first-page":"188","article-title":"Hypotensive and hypertensive effects of acetaldehyde on blood pressure in rats","volume":"43","author":"Satoh","year":"2008","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"key":"B40-20230813","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.toxlet.2013.06.231","article-title":"Diglycolic acid inhibits succinate dehydrogenase activity in human proximal tubule cells leading to mitochondrial dysfunction and cell death","volume":"221","author":"Landry","year":"2013","journal-title":"Toxicol Lett"},{"key":"B41-20230813","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM197305242882107","article-title":"Salicylate intoxication","volume":"288","author":"Hill","year":"1973","journal-title":"N Engl J Med"},{"key":"B42-20230813","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/15563650600907140","article-title":"Salicylate poisoning: An evidence-based consensus guideline for out-of-hospital management","volume":"45","author":"Chyka","year":"2007","journal-title":"Clin Toxicol (Phila)"},{"key":"B43-20230813","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3109\/15563650.2014.946994","article-title":"Extracorporeal treatment for acetaminophen poisoning: Recommendations from the EXTRIP workgroup","volume":"52","author":"Gosselin","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"B44-20230813","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13181-016-0542-z","article-title":"ACMT position statement: Duration of intravenous acetylcysteine therapy following acetaminophen overdose","volume":"13","year":"2017","journal-title":"J Med Toxicol"},{"key":"B45-20230813","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.wnf.0000150871.52253.b7","article-title":"The syndrome of irreversible lithium-effectuated neurotoxicity","volume":"28","author":"Adityanjee","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"B46-20230813","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/j.1552-4604.1994.tb02053.x","article-title":"Hyperlithemia correction and persistent delirium","volume":"34","author":"Swartz","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"B47-20230813","first-page":"CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"B48-20230813","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"B49-20230813","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/096032719000900509","article-title":"Morphine-6-glucuronide might mediate the prolonged opioid effect of morphine in acute renal failure","volume":"9","author":"Bodd","year":"1990","journal-title":"Hum Exp Toxicol"},{"key":"B50-20230813","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1345\/aph.1R784","article-title":"Tremors and agitation following low-dose intravenous hydromorphone administration in a patient with kidney dysfunction","volume":"47","author":"Gagnon","year":"2013","journal-title":"Ann Pharmacother"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.02560319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:10Z","timestamp":1786369150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.02560319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.02560319","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]}}}